公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2014 | Sorafenib relieves cell-intrinsic and cell-extrinsic inhibitions of effector T cells in tumor microenvironment to augment antitumor immunity | Chen M.-L.; BO-SHIUN YAN ; Lu W.-C.; Chen M.-H.; SUNG-LIANG YU ; PAN-CHYR YANG ; ANN-LII CHENG | International Journal of Cancer | 98 | 94 | |
2008 | Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy | CHIH-HSIN YANG ; CHONG-JEN YU ; JIN-YUAN SHIH ; YEUN-CHUNG CHANG ; Hu F.-C.; Tsai M.-C.; KUAN-YU CHEN ; ZHONG-ZHE LIN ; Huang C.-J.; CHIA-TUNG SHUN ; Huang C.-L.; Bean J.; ANN-LII CHENG ; Pao W.; PAN-CHYR YANG | Journal of Clinical Oncology | 240 | 224 | |
1997 | Stability of curcumin in buffer solutions and characterization of its degradation products | Wang Y.-J.; Pan M.-H.; ANN-LII CHENG ; LIANG-IN LIN ; Ho Y.-S.; CHANG-YAO HSIEH ; Lin J.-K. | Journal of Pharmaceutical and Biomedical Analysis | 1436 | 1302 | |
2015 | Statin Use Is Associated With Improved Prognosis of Colorectal Cancer in Taiwan | YU-YUN SHAO ; CHIH-HUNG HSU ; KUN-HUEI YEH ; Chen H.-M.; Yeh Y.-C.; Lai C.-L.; ZHONG-ZHE LIN ; ANN-LII CHENG ; Lai M.-S. | Clinical Colorectal Cancer | 35 | 32 | |
2003 | Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma | ANN-LII CHENG ; Hsiung C.A.; Su I.-J.; PEI-JER CHEN ; Chang M.-C.; Tsao C.-J.; Kao W.-Y.; Uen W.-C.; CHIH-HUNG HSU ; HWEI-FANG TIEN ; Chao T.-Y.; Chen L.-T.; Whang-Peng J. | Hepatology | 264 | 226 | |
1996 | Steroid-free chemotherapy decreases the risk of hepatitis flare-up in hepatitis B virus carriers with non-Hodgkin's lymphoma [3] | ANN-LII CHENG | Blood | 71 | 59 | |
2009 | Strategies to prevent hepatitis B virus reactivation in patients receiving immunosuppressive therapy | CHIUN HSU ; SHU-CHEN WEI ; ANN-LII CHENG ; PEI-JER CHEN | Hepatology | 4 | 3 | |
2014 | Strategy for Preventing Hepatitis B Reactivation in Patients With Resolved Hepatitis B Virus Infection After Rituximab-Containing Chemotherapy Reply | CHIUN HSU ; PEI-JER CHEN ; ANN-LII CHENG | Hepatology | 0 | 0 | |
2007 | Sulfasalazine suppresses drug resistance and invasiveness of lung adenocarcinoma cells expressing AXL | Lay J.-D.; Hong C.-C.; Huang J.-S.; Yang Y.-Y.; Pao C.-Y.; Liu C.-H.; Lai Y.-P.; Lai G.-M.; ANN-LII CHENG ; Su I.-J.; Chuang S.-E. | Cancer Research | 97 | 86 | |
2013 | Sunitinib versus sorafenib in advanced hepatocellular cancer: Results of a randomized phase III trial | ANN-LII CHENG ; Kang Y.-K.; Lin D.-Y.; Park J.-W.; Kudo M.; Qin S.; Chung H.-C.; Song X.; Xu J.; Poggi G.; Omata M.; Lowenthal S.P.; Lanzalone S.; Yang L.; Lechuga M.J.; Raymond E. | Journal of Clinical Oncology | 619 | 599 | |
2004 | Suppression of MEK/ERK signaling pathway enhances cisplatin-induced NF-κB activation by protein phosphatase 4-mediated NF-κB p 65 Thr dephosphorylation | Yeh P.Y.; KUN-HUEI YEH ; Chuang S.-E.; Song Y.C.; ANN-LII CHENG | Journal of Biological Chemistry | 96 | 90 | |
2005 | Survival of stage IIIB/IV non-small cell lung cancer patients who received chemotherapy but did not participate in clinical trials | SUNG-HSIN KUO ; CHIH-HSIN YANG ; CHONG-JEN YU ; CHIUN HSU ; ANN-LII CHENG ; PAN-CHYR YANG | Lung Cancer | 7 | 7 | |
2005 | Survival outcome of inoperable non-small cell lung cancer patients receiving conventional dose epirubicin and paclitaxel as first-line treatment | CHIH-HSIN YANG ; Chen M.-C.; ANN-LII CHENG ; CHIH-HUNG HSU ; KUN-HUEI YEH ; Yu Y.-C.; Whang-Peng J.; PAN-CHYR YANG | Oncology | 5 | 4 | |
2003 | Survival-weighted health profile for long-term survivors of acute myelogenous leukemia | CHIUN HSU ; Wang J.-D.; Hwang J.-S.; HWEI-FANG TIEN ; Chang S.-M.; ANN-LII CHENG ; YAO-CHANG CHEN ; JIH-LUH TANG | Quality of Life Research | 28 | 24 | |
2010 | The synergistic anticancer effect of troglitazone combined with aspirin causes cell cycle arrest and apoptosis in human lung cancer cells | Yan K.-H.; Yao C.-J.; Chang H.-Y.; Lai G.-M.; ANN-LII CHENG ; Chuang S.-E. | Molecular Carcinogenesis | 45 | 39 | |
2015 | Synergistic blockade of EGFR and HER2 by new-generation EGFR tyrosine kinase inhibitor enhances radiation effect in bladder cancer cells | YU-CHIEH TSAI ; Ho P.-Y.; KAI-YUAN TZEN ; Tuan T.-F.; Liu W.-L.; ANN-LII CHENG ; YEONG-SHIAU PU ; CHIA-HSIEN CHENG | Molecular Cancer Therapeutics | 25 | 26 | |
2009 | Synergistic Effect of Radiation and Interleukin-6 on Hepatitis B Virus Reactivation in Liver Through STAT3 Signaling Pathway | Chou C.H.; PEI-JER CHEN ; YUNG-MING JENG ; ANN-LII CHENG ; Huang L.-R.; CHIA-HSIEN CHENG | International Journal of Radiation Oncology Biology Physics | 22 | 23 | |
2023 | Synergistic efficacy of telomerase-specific oncolytic adenoviral therapy and histone deacetylase inhibition in human hepatocellular carcinoma | ZHONG-ZHE LIN ; Hu, Mickey C-T; CHIUN HSU ; YAO-MING WU ; YEN-SHEN LU ; Ho, Ja-An Annie; Shiou-Hwei Yeh ; PEI-JER CHEN ; ANN-LII CHENG | Cancer letters | 1 | 1 | |
2010 | Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivation | Chen K.-F.; Yu H.-C.; TSUNG-HAO LIU ; SHOEI-SHENG LEE ; PEI-JER CHEN ; ANN-LII CHENG | Journal of Hepatology | 68 | 67 | |
1998 | Systemic chemotherapy alone for patients with non-acquired immunodeficiency syndrome-related central nervous system lymphoma: A pilot study of the BOMES protocol | ANN-LII CHENG ; KUN-HUEI YEH ; Uen W.-C.; Hung R.-L.; Liu M.-Y.; Wang C.-H. | Cancer | 61 |